Please click here to download a copy of this information.

Dermaline Dermal Filler Safety Data Sheet

SDS Name：Sodium Hyaluronate

Synonyms: Hyaluronic Acid, Sodium Salt

Distributor: LT Products Ltd. – 524-528 Christchurch Road, Bournemouth, BH1 4BE

For information, call: 01202 876734
For emergencies, call: 01202 876734

SECTION 2: INGREDIENTS

CAS# Chemical Name content EINECS#
9067-32-7 Sodium Hyaluronate ≥91.0% unlisted
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

SECTION 3 – HAZARDS IDENTIFICATION

EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye: No information regarding eye irritation and other potential effects was found.
Skin:
-2
No information regarding skin irritation and other potential effects was found.
Ingestion:
The toxicological properties of this substance have not been fully investigated.
Inhalation:
The toxicological properties of this substance have not been fully investigated.
Inhalation of dust may cause respiratory tract irritation.
Chronic:
No information found.

SECTION 4 – FIRST AID MEASURES

Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin: Get medical aid immediately. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion: If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical aid
Inhalation: Get medical aid immediately. Remove from exposure and move to fresh air
If not breathing, give artificial respiration. If breathing is difficult, give oxygen.

SECTION 5 – FIRE FIGHTING MEASURES
None

SECTION 6 – ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in
Section 8.

Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

SECTION 7 – HANDLING and STORAGE

Handling:
Wash thoroughly after handling. Use only in a well-ventilated area.
Avoid contact with skin and eyes. Avoid ingestion and inhalation.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

SECTION 8 – EXPOSURE CONTROLS, PERSONAL PROTECTION

Skin: Wear appropriate protective gloves to prevent skin exposure.
Clothing: Wear appropriate protective clothing to prevent skin exposure.
Respirators: Follow the OSHA respirator regulations found in 29 CFR 1910.134 or
European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149
approved respirator if exposure limits are exceeded or if irritation or other
symptoms are experienced.

SECTION 9 – PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Gel
Colour: Transparent

Decomposition Temperature:
Solubility in water: soluble in water
Specific Gravity/Density: ≥91.0%
Molecular Formula: (C14H20NNaO11)n
Molecular Weight: ≥90D

SECTION 10 – STABILITY AND REACTIVITY

Chemical Stability:
Stable.

SECTION 11 – TOXICOLOGICAL INFORMATION

RTECS#:
CAS# 9067-32-7: MT7250000 LD50/LC50:
CAS# 9067-32-7: Oral, mouse: LD50 = >2400 mg/kg; Oral, rabbit: LD50 = >1
gm/kg; Oral, rat: LD50 = >800 mg/kg.
Carcinogenicity:
Sodium Hyaluronate – Not listed by ACGIH, IARC, or NTP.

SECTION 12 – ECOLOGICAL INFORMATION

NONE

SECTION 13 – DISPOSAL CONSIDERATIONS

Disposal should be in accordance with accepted medical practice and applicable national, local or
institutional guidelines.

SECTION 14 – TRANSPORT INFORMATION

NONE

SECTION 16- OTHER INFORMATION

NONE